Gritstone Bio News

Gritstone Bio to Report First Quarter 2024 Financial Results and Provide Corporate Updates on May 9, 2024

PDF Version -- Conference call and webcast to begin at 4:30pm ET --EMERYVILLE, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology compan

Gritstone BioMay 2 00:00 ET

Express News | Gritstone Bio Highlights The Durability and Potential Broad Utility of Its Self-amplifying MRNA COVID-19 Vaccine at ESCMID Global 2024

BenzingaApr 30 07:16 ET

Express News | Gritstone bio Highlights the Durability and Potential Broad Utility of Its Self-Amplifying Mrna (Samrna) Covid-19 Vaccine at Escmid Global 2024

ReutersApr 30 07:08 ET

Gritstone Bio Highlights the Durability and Potential Broad Utility of Its Self-amplifying MRNA (SamRNA) COVID-19 Vaccine at ESCMID Global 2024

PDF Version -- IgG levels and neutralizing antibodies against variants of concern persisted for at least 12 months, consistent with previous findings ---- Antigen-specific T cell responses increa

Gritstone BioApr 30 00:00 ET

Express News | Gritstone bio Announces Appointment of Stephen Webster to Its Board of Directors

ReutersApr 29 07:00 ET

Express News | Gritstone bio Inc : B. Riley Cuts Target Price to $3 From $6

Moomoo 24/7Apr 17 01:48 ET

Nature Medicine Publishes Interim Results From Gritstone Bio's Phase 1/2 Study of "Off-the-Shelf" Neoantigen Vaccine Platform (SLATE)

PDF Version -- Paper details vaccine design optimization process of Gritstone's "off-the-shelf" or shared neoantigen vaccine platform, SLATE ---- Discovery of a novel immunodominance hierarchy of

Gritstone BioApr 15 00:00 ET

Gritstone Bio, Inc. (GRTS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors...

Stockhouse Apr 8 11:00 ET

Express News | Gritstone Bio Presented An Update On Its T Cell Epitope Discovery Platform, EDGE, At AACR 2024, Highlighting Improvements In Prediction Of Peptide Presentation By HLA Class I, Associated With CD8+ T Cells, Since Initial Results In 2018

Moomoo 24/7Apr 8 07:26 ET

Gritstone Bio Presents Improvements to EDGE Platform at AACR 2024

PDF Version -- State-of-the-art neoantigen prediction platform (EDGE) now predicts HLA Class I presentation of epitopes with >80% accuracy ---- Newly developed EDGE-II model achieves superior pre

Gritstone BioApr 8 00:00 ET

Gritstone Bio to Participate in Upcoming Investor and Scientific Conferences

PDF Version EMERYVILLE, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world's most potent vaccines

Gritstone BioApr 8 00:00 ET

Express News | JMP Securities Maintains Market Outperform on Gritstone Bio, Raises Price Target to $5

Moomoo 24/7Apr 2 14:09 ET

Canopy Growth, Exact Sciences, Stereotaxis Among Healthcare Movers

Seeking AlphaApr 2 10:00 ET

Express News | Gritstone Bio Shares Are Trading Lower After the Company Announced a $32.5 Million Underwritten Public Offering of 8,333,333 Shares of Common Stock and Accompanying Common Warrants at $1.50 per Share

Moomoo 24/7Apr 2 08:16 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

GainersMSP Recovery (NASDAQ:LIFW) stock increased by 61.9% to $1.08 during Tuesday's pre-market session. The company's market cap stands at $15.9 million. Serina Therapeutics (AMEX:SER) stock moved up

BenzingaApr 2 08:07 ET

Paychex, PVH And 3 Stocks To Watch Heading Into Tuesday

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Paychex, Inc. (NASDAQ:PAYX) to report quarter

BenzingaApr 2 07:14 ET

Gritstone Bio Shares Drop 33% After Public Offering Prices

By Chris Wack Gritstone bio shares were down 33% to $1.57 in premarket trading after the company priced a $32.5 million underwritten public offering of its stock and accompanying warrants. The biote

WSJApr 2 06:16 ET

TD Cowen, Evercore ISI Acting as Book-Running Managers for Gritstone Bio Offering >GRTS

TD Cowen, Evercore ISI Acting as Book-Running Managers for Gritstone Bio Offering >GRTS

Dow JonesApr 1 23:08 ET

Gritstone Bio Offering to Close on or About April 4 >GRTS

Gritstone Bio Offering to Close on or About April 4 >GRTS

Dow JonesApr 1 23:08 ET

Gritstone Bio Announces Pricing of $32.5 Million Underwritten Public Offering

EMERYVILLE, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (NASDAQ:GRTS), a clinical-stage biotechnology company working to develop the world's most potent vaccines, today announced the pricing of an

GlobeNewswireApr 1 23:00 ET